Risk factors in depression in oncology patients. Dr. Julio Villacreses Colmont Hospital
DOI:
https://doi.org/10.56294/mw2024660Keywords:
Depression, cancer, anxiety, risk factors, psychological supportAbstract
The general objective of this study was to analyze the risk factors for depression in patients with an oncological diagnosis treated at the Dr. Julio Villacreses Colmont Hospital in Portoviejo. A descriptive and cross-sectional design was used, applying a sociodemographic file and the Hospital Anxiety and Depression Scale (HAD) to a sample of 242 patients. The results revealed that 33% of the patients had severe depression, while 42% showed moderate depression. In terms of anxiety levels, 30% of participants experienced severe anxiety and 41% moderate anxiety. The most prevalent types of cancer were prostate and lung, with most diagnoses in advanced stages (III and IV). A high rate of comorbidities was identified, present in 52% of patients, which complicated treatment and affected prognosis. In conclusion, the high levels of anxiety and depression in cancer patients highlight the importance of integrating psychological support into their care, promoting a comprehensive approach that improves both quality of life and clinical outcomes.
References
Mössinger, H., Kostev, K. Depression Is Associated with an Increased Risk of Subsequent Cancer Diagnosis: A Retrospective Cohort Study with 235,404 Patients. Brain Sciences. 2023;13. https://doi.org/10.3390/brainsci13020302
Yan, X., Chen, X., Zhang, P. Prevalence and risk factors of depression in patients with lung cancer: protocol for a systematic review and meta-analysis. BMJ Open. 2019;9. https://doi.org/10.1136/bmjopen-2019-028994
Wang, Y., Li, J., Shi, J., Que, J., Liu, J., Lappin, J., Leung, J., Ravindran, A., Chen, W., Qiao, Y., Shi, J., Lu, L., Bao, Y. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Molecular Psychiatry. 2019;25:1487-1499. https://doi.org/10.1038/s41380-019-0595-x
Boakye, E. A., Osazuwa-Peters, N., Mohammed, K. A., Challapalli, S., Buchanan, P., Burroughs, T., Varvares, M. Prevalence and factors associated with diagnosed depression among hospitalized cancer patients with metastatic disease. Social Psychiatry and Psychiatric Epidemiology. 2019;55:15-23. https://doi.org/10.1007/s00127-019-01763-1
Kjaer, T., Moustsen-Helms, I. R., Albieri, V., Larsen, S., Degett, T. H., Tjønneland, A., Johansen, C., Kjaer, S., Gøgenur, I., Dalton, S. Risk of Pharmacological or Hospital Treatment for Depression in Patients with Colorectal Cancer–Associations with Pre-Cancer Lifestyle, Comorbidity and Clinical Factors. Cancers. 2021;13. https://doi.org/10.3390/cancers13081979
López-Roig S, Terol MC, Pastor MA, Neipp MC, Massutí B, Rodríguez-Marín L. Ansiedad y depresión. Validación de la escala HAD en pacientes oncológicos. PSSA [Internet]. 27 de abril de 2017 [citado 2 de noviembre de 2023];12(2):127-55. Disponible en:
https://revistas.innovacionumh.es/index.php/psicologiasalud/article/view/787
Hassan, S. A., Elzeiny, H. H. A., Hussein, N., Karim, A. Clinical Parameters of Cancer Patients and their Relation with Depression Level. Zagazig Nursing Journal. 2022. https://doi.org/10.21608/znj.2022.269336
Robbertz, A. S., Weiss, D. M., Awan, F., Byrd, J., Rogers, K., Woyach, J. Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemia. Supportive Care in Cancer. 2019;28:1799-1807. https://doi.org/10.1007/s00520-019-04991-y
Ghanem, I., Castelo, B., Jiménez-Fonseca, P., Carmona-Bayonas, A., Higuera, O., Beato, C., García, T., Hernández, R., Calderón, C. Coping strategies and depressive symptoms in cancer patients. Clinical and Translational Oncology. 2020;22:330-336. https://doi.org/10.1007/s12094-019-02123-w
Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y., Wang, Z. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Molecular Psychiatry. 2020;25:3186-3197. https://doi.org/10.1038/s41380-020-00865-6
Naser, A., Hameed, A. N., Mustafa, N., Alwafi, H., Dahmash, E., Alyami, H., Khalil, H. Depression and Anxiety in Patients With Cancer: A Cross-Sectional Study. Frontiers in Psychology. 2021;12. https://doi.org/10.3389/fpsyg.2021.585534
Sönmez, I., Balıkçı, K., Denizgil, T., Aydın, O., Andrieu, M. N. The trait anxiety as a predictor of the suicidal risk in patients with cancer. Indian Journal of Psychiatry. 2020;62:87-90. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_425_18
Ladaninejad, S., Ilali, E., Mousavinasab, N., Taraghi, Z. The Relationship between Depressive Symptoms and Demographic-Medical Characteristics among Elder People with Cancer. Asia-Pacific Journal of Oncology Nursing. 2019;6:424-430. https://doi.org/10.4103/apjon.apjon_13_19
Roy, A., Konda, M., Warrier, A., Arnaoutakis, K. Depression in lung cancer patients: A nationwide analysis. Journal of Clinical Oncology. 2019. https://doi.org/10.1200/jco.2019.37.31_suppl.83
Schellekens, M., Wolvers, M., Schroevers, M., Bootsma, T. I., Cramer, A., van der Lee, M. L. Exploring the interconnectedness of fatigue, depression, anxiety and potential risk and protective factors in cancer patients: a network approach. Journal of Behavioral Medicine. 2019;43:553-563. https://doi.org/10.1007/s10865-019-00084-7
Kuba, K., Esser, P., Mehnert, A., Hinz, A., Johansen, C., Lordick, F., Götze, H. Risk for Depression and Anxiety in Long-Term Survivors of Hematologic Cancer. Health Psychology. 2019;38:187-195. https://doi.org/10.1037/hea0000713
Cotchett, K. R., Kelly, A., Szabo, A., Cheng, Y., Kamaraju, S., Chitambar, C., Wallace, L., Chaudhary, L. N., Burfeind, J. Depression and Psychological Distress in Breast Cancer Patients. Cancer Research. 2023. https://doi.org/10.1158/1538-7445.sabcs22-p6-05-34
Abrebak, H., Chamsi, F. Z., Essafi, A., Taqui, A., Radi, S., El ammouri, A. Suicide in cancer patients: incidence and risk factors (literature review). European Psychiatry. 2023;66 https://doi.org/10.1192/j.eurpsy.2023.234
Walker, J. L., Mulick, A., Magill, N., Symeonides, S., Gourley, C., Burke, K., Belot, A., Quartagno, M., van Niekerk, M., Toynbee, M., Frost, C., Sharpe, M. Major Depression and Survival in People With Cancer. Psychosomatic Medicine. 2021;83:410-416. https://doi.org/10.1097/PSY.0000000000000942
Shyu, I. L., Hu, L. Y., Chen, Y. J., Wang, P. H., Huang, B. Risk factors for developing depression in women with cervical cancer: a nationwide population-based study in Taiwan. International Journal of Women's Health. 2019;11:135-141. https://doi.org/10.2147/IJWH.S193003
Habimana, S., Biracyaza, E., Mpunga, T., Nsabimana, E., Kayitesi, F., Nzamwita, P., Jansen, S. Prevalence and associated factors of depression and anxiety among patients with cancer seeking treatment at the Butaro Cancer Center of Excellence in Rwanda. Frontiers in Public Health. 2023;11. https://doi.org/10.3389/fpubh.2023.972360
Westin S, Louie-Gao M, Gupta D, Thaker P. Risk factors for progression or death after first-line platinum-based chemotherapy in real-world patients in the USA with ovarian cancer from 2011 to 2018. Future Oncol. 2021;17(12):1383-1393. https://doi.org/10.2217/fon-2021-0018
Vincent L, Jankowski C, Ouldamer L, Ballester M, Bendifallah S, Bolze P, et al. Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group. Eur J Surg Oncol. 2020;46(7):1319-1326. https://doi.org/10.1016/j.ejso.2020.04.029
Chase D, Perhanidis J, Gupta D, Kalilani L, Golembesky A, González-Martín A. Association of multiple high-risk factors on observed outcomes in real-world patients with advanced ovarian cancer treated with first-line therapy. JCO Clin Cancer Inform. 2023;7. https://doi.org/10.1200/CCI.22.00189
Liu KH, Hung CY, Hsueh S, Chang PH, Chen YY, Lu C, et al. Lung metastases in patients with stage IV pancreatic cancer: Prevalence, risk factors, and survival impact. J Clin Med. 2019;8(9):1402. https://doi.org/10.3390/jcm8091402
Westin S, Louie-Gao M, Badamgarav E, Bala M, Thaker P. Risk factors for progression or death in ovarian cancer patients who completed first-line platinum treatment. J Clin Oncol. 2019;37(15_suppl):5548. https://doi.org/10.1200/JCO.2019.37.15_SUPPL.5548
Sinukumar S, Damodaran D, Ray M, Mehta S, Paul L, Bhatt A. Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer. Eur J Surg Oncol. 2021;47(5):1156-1163. https://doi.org/10.1016/j.ejso.2021.01.013
Dincă AL, Bîrla R, Dincă V, Marica C, Panaitescu E, Constantinoiu S. Prognostic factors in advanced ovarian cancer – A clinical trial. Chirurgia (Bucur). 2020;115(1):50-62. https://doi.org/10.21614/chirurgia.115.1.50
Kim HC, Ji W, Lee JC, Kim H, Song S, Choi CM. Prognostic factor and clinical outcome in stage III non-small cell lung cancer: A study based on real-world clinical data in the Korean population. Cancer Res Treat. 2021;53(4):1033-1041. https://doi.org/10.4143/crt.2020.1350
Iwagoi Y, Motohara T, Hwang S, Fujimoto K, Ikeda T, Katabuchi H. Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer. Int J Clin Oncol. 2021;26(6):995-1004. https://doi.org/10.1007/s10147-021-01866-3
Chen X, Hou L, Shen Y, Wu X, Dong B, Hao Q. The role of baseline sarcopenia index in predicting chemotherapy-induced undesirable effects and mortality in older people with stage III or IV non-small cell lung cancer. J Nutr Health Aging. 2021;25(7):878-882. https://doi.org/10.1007/s12603-021-1633-3
Zhu HJ, Nichols R, Henderson R, Morris C, Flampouri S, Pham D, et al. Impact of unfavorable factors on outcomes among inoperable stage II-IV non-small cell lung cancer patients treated with proton therapy. Acta Oncol. 2019;58(3):313-319. https://doi.org/10.1080/0284186X.2018.1546060
Gao F, Li N, Xu Y, Yang G. Effects of postoperative radiotherapy on survival of patients with stage IIIA resected non-small cell lung cancer: Analysis of the SEER database. J Natl Compr Canc Netw. 2020;18(6):718-727. https://doi.org/10.6004/jnccn.2020.7537
Aoki T, Akiba T, Nishiyama J, Tajiri S, Hayama N, Takahashi G, et al. Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients. Respir Res. 2019;20:1235. https://doi.org/10.1186/s12931-019-1235-3
Chen X, Hou L, Shen Y, Wu X, Dong B, Hao Q. The role of baseline sarcopenia index in predicting chemotherapy-induced undesirable effects and mortality in older people with stage III or IV non-small cell lung cancer. J Nutr Health Aging. 2021;25(7):878-882. https://doi.org/10.1007/s12603-021-1633-3
Published
Issue
Section
License
Copyright (c) 2024 Mayra Viviana Zambrano Escobar, Julia Teresa Espinel García (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
